Covered recipient · General Payments record
DAVID W HAYES
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$5,865.17
- Reported across 248 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $988.89 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $477.45 | 19 |
| Sight Sciences, Inc. | $107.52 | 2 |
| GLAUKOS CORPORATION | $106.67 | 3 |
| Tarsus Pharmaceuticals, Inc. | $98.79 | 4 |
| Ocular Therapeutix, Inc. | $50.25 | 1 |
| Amgen Inc. | $48.07 | 1 |
| Bausch & Lomb Americas Inc. | $47.40 | 2 |
| Alcon Laboratories Inc | $32.74 | 2 |
| Biogen, Inc. | $20.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.85 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895086 | CMS |
| ABBVIE INC. | $3.82 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895088 | CMS |
| ABBVIE INC. | $15.02 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895090 | CMS |
| ABBVIE INC. | $23.00 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895092 | CMS |
| ABBVIE INC. | $13.03 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895094 | CMS |
| ABBVIE INC. | $27.68 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895096 | CMS |
| ABBVIE INC. | $12.89 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895098 | CMS |
| ABBVIE INC. | $24.53 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895100 | CMS |
| ABBVIE INC. | $21.52 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895102 | CMS |
| ABBVIE INC. | $19.12 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895104 | CMS |
| ABBVIE INC. | $18.26 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895106 | CMS |
| ABBVIE INC. | $18.74 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895108 | CMS |
| ABBVIE INC. | $22.32 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895110 | CMS |
| ABBVIE INC. | $14.44 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895112 | CMS |
| ABBVIE INC. | $27.18 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895114 | CMS |
| ABBVIE INC. | $120.87 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895116 | CMS |
| ABBVIE INC. | $24.74 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895118 | CMS |
| ABBVIE INC. | $17.30 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895120 | CMS |
| ABBVIE INC. | $22.14 | 12/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895122 | CMS |
| Alcon Vision LLC | $16.49 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110699024 | CMS |
| Alcon Vision LLC | $16.25 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110699022 | CMS |
| Amgen Inc. | $48.07 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111596690 | CMS |
| Bausch & Lomb Americas Inc. | $24.10 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140331727 | CMS |
| Bausch & Lomb Americas Inc. | $23.30 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140331729 | CMS |
| Biogen, Inc. | $20.00 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104827024 | CMS |
| Glaukos Corporation | $24.68 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983932 | CMS |
| Glaukos Corporation | $15.63 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983930 | CMS |
| Glaukos Corporation | $66.36 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983934 | CMS |
| Ocular Therapeutix, Inc. | $50.25 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148197961 | CMS |
| Sight Sciences, Inc. | $22.52 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151933561 | CMS |
| Sight Sciences, Inc. | $85.00 | 12/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151933563 | CMS |
| Tarsus Pharmaceuticals, Inc. | $35.29 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139102209 | CMS |
| Tarsus Pharmaceuticals, Inc. | $24.30 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139102211 | CMS |
| Tarsus Pharmaceuticals, Inc. | $16.57 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139102213 | CMS |
| Tarsus Pharmaceuticals, Inc. | $22.63 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139102215 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.